Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 128

1.

International trends in hepatocellular carcinoma incidence, 1978-2012.

Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, Ferlay J, Valery PC, Bray F, McGlynn KA.

Int J Cancer. 2019 Oct 9. doi: 10.1002/ijc.32723. [Epub ahead of print]

PMID:
31597196
2.

Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.

Arnold M, Rutherford MJ, Bardot A, Ferlay J, Andersson TM, Myklebust TÅ, Tervonen H, Thursfield V, Ransom D, Shack L, Woods RR, Turner D, Leonfellner S, Ryan S, Saint-Jacques N, De P, McClure C, Ramanakumar AV, Stuart-Panko H, Engholm G, Walsh PM, Jackson C, Vernon S, Morgan E, Gavin A, Morrison DS, Huws DW, Porter G, Butler J, Bryant H, Currow DC, Hiom S, Parkin DM, Sasieni P, Lambert PC, Møller B, Soerjomataram I, Bray F.

Lancet Oncol. 2019 Nov;20(11):1493-1505. doi: 10.1016/S1470-2045(19)30456-5. Epub 2019 Sep 11.

3.

International Trends in the Incidence of Testicular Cancer: Lessons from 35 Years and 41 Countries.

Gurney JK, Florio AA, Znaor A, Ferlay J, Laversanne M, Sarfati D, Bray F, McGlynn KA.

Eur Urol. 2019 Nov;76(5):615-623. doi: 10.1016/j.eururo.2019.07.002. Epub 2019 Jul 17.

PMID:
31324498
4.

The burden of squamous cell carcinoma of the conjunctiva in Africa.

Hämmerl L, Ferlay J, Borok M, Carrilho C, Parkin DM.

Cancer Epidemiol. 2019 Aug;61:150-153. doi: 10.1016/j.canep.2019.06.007. Epub 2019 Jun 27.

PMID:
31255960
5.

Cancer in Africa 2018: The role of infections.

Parkin DM, Hämmerl L, Ferlay J, Kantelhardt EJ.

Int J Cancer. 2019 Jun 29. doi: 10.1002/ijc.32538. [Epub ahead of print]

PMID:
31254479
6.

Changes in colorectal cancer incidence in seven high-income countries: a population-based study.

Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, De P, Tervonen H, Walsh PM, Bucher O, Engholm G, Jackson C, McClure C, Woods RR, Saint-Jacques N, Morgan E, Ransom D, Thursfield V, Møller B, Leonfellner S, Guren MG, Bray F, Arnold M.

Lancet Gastroenterol Hepatol. 2019 Jul;4(7):511-518. doi: 10.1016/S2468-1253(19)30147-5. Epub 2019 May 16. Erratum in: Lancet Gastroenterol Hepatol. 2019 Aug;4(8):e8.

PMID:
31105047
7.

Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study.

Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB.

Lancet Oncol. 2019 Jun;20(6):769-780. doi: 10.1016/S1470-2045(19)30163-9. Epub 2019 May 8. Erratum in: Lancet Oncol. 2019 Jul;20(7):e346.

PMID:
31078462
8.

Aging and the cancer burden in Latin America and the Caribbean: Time to act.

Pilleron S, Soerjomataram I, Soto-Perez-de-Celis E, Ferlay J, Vega E, Bray F, Piñeros M.

J Geriatr Oncol. 2019 Sep;10(5):799-804. doi: 10.1016/j.jgo.2019.02.014. Epub 2019 Mar 7.

PMID:
30853302
9.

Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.

Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F.

Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.

PMID:
30350310
10.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.

CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.

11.

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.

Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, Gavin A, Visser O, Bray F.

Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. Review.

PMID:
30100160
12.

Global cancer incidence in older adults, 2012 and 2035: A population-based study.

Pilleron S, Sarfati D, Janssen-Heijnen M, Vignat J, Ferlay J, Bray F, Soerjomataram I.

Int J Cancer. 2019 Jan 1;144(1):49-58. doi: 10.1002/ijc.31664. Epub 2018 Oct 30.

PMID:
29978474
13.

The association between geographic location and incidence of Merkel cell carcinoma in comparison to melanoma: An international assessment.

Stang A, Becker JC, Nghiem P, Ferlay J.

Eur J Cancer. 2018 May;94:47-60. doi: 10.1016/j.ejca.2018.02.003. Epub 2018 Mar 20.

14.

Evaluation of data quality at the National Cancer Registry of Ukraine.

Ryzhov A, Bray F, Ferlay J, Fedorenko Z, Goulak L, Gorokh Y, Soumkina O, Znaor A.

Cancer Epidemiol. 2018 Apr;53:156-165. doi: 10.1016/j.canep.2018.02.002. Epub 2018 Feb 22.

PMID:
29459256
15.

Young adults: a unique group in cancer epidemiological research - Authors' reply.

Fidler MM, Steliarova-Foucher E, Soerjomataram I, Ferlay J, Gupta S, Bray F.

Lancet Oncol. 2018 Feb;19(2):e73. doi: 10.1016/S1470-2045(18)30032-9. No abstract available.

PMID:
29413474
16.

Epidemiological patterns of leukaemia in 184 countries: a population-based study.

Miranda-Filho A, Piñeros M, Ferlay J, Soerjomataram I, Monnereau A, Bray F.

Lancet Haematol. 2018 Jan;5(1):e14-e24. doi: 10.1016/S2352-3026(17)30232-6.

PMID:
29304322
17.

Estimating the number of fractions by tumour site for European countries in 2012 and 2025: An ESTRO-HERO analysis.

Borras JM, Grau C, Corral J, Wong K, Barton MB, Ferlay J, Bray F, Lievens Y.

Radiother Oncol. 2018 Feb;126(2):198-204. doi: 10.1016/j.radonc.2017.11.009. Epub 2017 Nov 29.

PMID:
29198408
18.

Cancer incidence and mortality among young adults aged 20-39 years worldwide in 2012: a population-based study.

Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E, Bray F.

Lancet Oncol. 2017 Dec;18(12):1579-1589. doi: 10.1016/S1470-2045(17)30677-0. Epub 2017 Oct 27.

19.

Cancer incidence in English children, adolescents and young people: past trends and projections to 2030.

Pesola F, Ferlay J, Sasieni P.

Br J Cancer. 2017 Dec 5;117(12):1865-1873. doi: 10.1038/bjc.2017.341. Epub 2017 Nov 2.

20.

International Patterns and Trends in Endometrial Cancer Incidence, 1978-2013.

Lortet-Tieulent J, Ferlay J, Bray F, Jemal A.

J Natl Cancer Inst. 2018 Apr 1;110(4):354-361. doi: 10.1093/jnci/djx214.

PMID:
29045681
21.

RE: Anal cancer: different epidemiological and clinical definitions.

Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A.

Int J Epidemiol. 2017 Dec 1;46(6):2092-2093. doi: 10.1093/ije/dyx200. No abstract available.

PMID:
29024953
22.

Cancer of childhood in sub-Saharan Africa.

Stefan C, Bray F, Ferlay J, Liu B, Maxwell Parkin D.

Ecancermedicalscience. 2017 Jul 28;11:755. doi: 10.3332/ecancer.2017.755. eCollection 2017. Review.

23.

Cervical cancer in Africa, Latin America and the Caribbean and Asia: Regional inequalities and changing trends.

Vaccarella S, Laversanne M, Ferlay J, Bray F.

Int J Cancer. 2017 Nov 15;141(10):1997-2001. doi: 10.1002/ijc.30901. Epub 2017 Aug 10.

24.

The global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2012.

Shield KD, Ferlay J, Jemal A, Sankaranarayanan R, Chaturvedi AK, Bray F, Soerjomataram I.

CA Cancer J Clin. 2017 Jan;67(1):51-64. doi: 10.3322/caac.21384. Epub 2016 Oct 19.

25.

The Benefits of Providing External Beam Radiotherapy in Low- and Middle-income Countries.

Yap ML, Hanna TP, Shafiq J, Ferlay J, Bray F, Delaney GP, Barton M.

Clin Oncol (R Coll Radiol). 2017 Feb;29(2):72-83. doi: 10.1016/j.clon.2016.11.003. Epub 2016 Dec 1.

PMID:
27916340
26.

International trends in anal cancer incidence rates.

Islami F, Ferlay J, Lortet-Tieulent J, Bray F, Jemal A.

Int J Epidemiol. 2017 Jun 1;46(3):924-938. doi: 10.1093/ije/dyw276.

PMID:
27789668
27.

More deaths from pancreatic cancer than breast cancer in the EU by 2017.

Ferlay J, Partensky C, Bray F.

Acta Oncol. 2016 Sep - Oct;55(9-10):1158-1160. doi: 10.1080/0284186X.2016.1197419. Epub 2016 Aug 23.

PMID:
27551890
28.

Global burden of cancers attributable to infections in 2012: a synthetic analysis.

Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S.

Lancet Glob Health. 2016 Sep;4(9):e609-16. doi: 10.1016/S2214-109X(16)30143-7. Epub 2016 Jul 25.

29.

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends.

Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F.

Eur Urol. 2017 Jan;71(1):96-108. doi: 10.1016/j.eururo.2016.06.010. Epub 2016 Jun 28. Review.

PMID:
27370177
30.

Disparities in time trends of cervical cancer mortality rates in Brazil.

Vale DB, Sauvaget C, Muwonge R, Ferlay J, Zeferino LC, Murillo R, Sankaranarayanan R.

Cancer Causes Control. 2016 Jul;27(7):889-96. doi: 10.1007/s10552-016-0766-x. Epub 2016 Jun 2.

PMID:
27255650
31.

Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade?

Yap ML, Zubizarreta E, Bray F, Ferlay J, Barton M.

J Glob Oncol. 2016 Mar 16;2(4):207-215. doi: 10.1200/JGO.2015.001545. eCollection 2016 Aug.

32.

An assessment of GLOBOCAN methods for deriving national estimates of cancer incidence.

Antoni S, Soerjomataram I, Møller B, Bray F, Ferlay J.

Bull World Health Organ. 2016 Mar 1;94(3):174-84. doi: 10.2471/BLT.15.164384. Epub 2016 Jan 28.

33.

How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.

Borras JM, Lievens Y, Barton M, Corral J, Ferlay J, Bray F, Grau C.

Radiother Oncol. 2016 Apr;119(1):5-11. doi: 10.1016/j.radonc.2016.02.016. Epub 2016 Feb 24.

34.

Obesity and the Incidence of Upper Gastrointestinal Cancers: An Ecological Approach to Examine Differences across Age and Sex.

Arnold M, Colquhoun A, Cook MB, Ferlay J, Forman D, Soerjomataram I.

Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):90-7. doi: 10.1158/1055-9965.EPI-15-0753. Epub 2015 Oct 22.

35.

Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group.

Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, Bray F, Cook MB, Devesa SS.

Int J Cancer. 2016 Mar 15;138(6):1388-400. doi: 10.1002/ijc.29894. Epub 2015 Nov 27.

36.

Improving the quality and coverage of cancer registries globally.

Bray F, Soerjomataram I, Mery L, Ferlay J.

Lancet. 2015 Sep 12;386(9998):1035-6. doi: 10.1016/S0140-6736(15)00135-X. No abstract available.

PMID:
26382988
37.

International Variation in Female Breast Cancer Incidence and Mortality Rates.

DeSantis CE, Bray F, Ferlay J, Lortet-Tieulent J, Anderson BO, Jemal A.

Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1495-506. doi: 10.1158/1055-9965.EPI-15-0535. Epub 2015 Sep 10.

38.

Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registration.

Bray F, Ferlay J, Laversanne M, Brewster DH, Gombe Mbalawa C, Kohler B, Piñeros M, Steliarova-Foucher E, Swaminathan R, Antoni S, Soerjomataram I, Forman D.

Int J Cancer. 2015 Nov 1;137(9):2060-71. doi: 10.1002/ijc.29670.

39.

Global patterns of cardia and non-cardia gastric cancer incidence in 2012.

Colquhoun A, Arnold M, Ferlay J, Goodman KJ, Forman D, Soerjomataram I.

Gut. 2015 Dec;64(12):1881-8. doi: 10.1136/gutjnl-2014-308915. Epub 2015 Mar 6.

PMID:
25748648
40.

Global cancer statistics, 2012.

Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A.

CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.

41.

Global burden of cancer attributable to high body-mass index in 2012: a population-based study.

Arnold M, Pandeya N, Byrnes G, Renehan PAG, Stevens GA, Ezzati PM, Ferlay J, Miranda JJ, Romieu I, Dikshit R, Forman D, Soerjomataram I.

Lancet Oncol. 2015 Jan;16(1):36-46. doi: 10.1016/S1470-2045(14)71123-4. Epub 2014 Nov 26.

42.

Regional geographic variations in kidney cancer incidence rates in European countries.

Li P, Znaor A, Holcatova I, Fabianova E, Mates D, Wozniak MB, Ferlay J, Scelo G.

Eur Urol. 2015 Jun;67(6):1134-1141. doi: 10.1016/j.eururo.2014.11.001. Epub 2014 Nov 18. Review.

PMID:
25465966
43.

Global incidence of oesophageal cancer by histological subtype in 2012.

Arnold M, Soerjomataram I, Ferlay J, Forman D.

Gut. 2015 Mar;64(3):381-7. doi: 10.1136/gutjnl-2014-308124. Epub 2014 Oct 15.

PMID:
25320104
44.

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F.

Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9.

45.

The ban on phenacetin is associated with changes in the incidence trends of upper-urinary tract cancers in Australia.

Antoni S, Soerjomataram I, Moore S, Ferlay J, Sitas F, Smith DP, Forman D.

Aust N Z J Public Health. 2014 Oct;38(5):455-8. doi: 10.1111/1753-6405.12252. Epub 2014 Aug 28.

PMID:
25169832
46.

Cancer in Africa 2012.

Parkin DM, Bray F, Ferlay J, Jemal A.

Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):953-66. doi: 10.1158/1055-9965.EPI-14-0281. Epub 2014 Apr 3.

47.

The European Cancer Observatory: A new data resource.

Steliarova-Foucher E, O'Callaghan M, Ferlay J, Masuyer E, Rosso S, Forman D, Bray F, Comber H.

Eur J Cancer. 2015 Jun;51(9):1131-43. doi: 10.1016/j.ejca.2014.01.027. Epub 2014 Feb 22.

PMID:
24569102
48.

International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women.

Lortet-Tieulent J, Soerjomataram I, Ferlay J, Rutherford M, Weiderpass E, Bray F.

Lung Cancer. 2014 Apr;84(1):13-22. doi: 10.1016/j.lungcan.2014.01.009. Epub 2014 Jan 25.

PMID:
24524818
49.

Data availability and presentation.

Steliarova-Foucher E, Ferlay J, Forman D, Piñeros M, Kohler B.

IARC Sci Publ. 2014;(164 Pt 1):116-23. No abstract available.

PMID:
27220131
50.

Age standardization.

Bray F, Ferlay J.

IARC Sci Publ. 2014;(164 Pt 1):112-5. No abstract available.

PMID:
27220130

Supplemental Content

Loading ...
Support Center